Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review

被引：23

作者：

Cohen, Joel L. ^{[1
,2
]}

Scuderi, Nicolo ^{[3
]}

机构：

[1] Univ Colorado, Dept Dermatol, Boulder, CO 80309 USA

[2] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA

[3] Sapienza Univ Rome, Dept Surg, Plast & Reconstruct Surg, Rome, Italy

来源：

AESTHETIC SURGERY JOURNAL | 2017年 / 37卷

关键词：

TOXIN TYPE-A; NEUROTOXIN TYPE-A; ANTIBODY-INDUCED FAILURE; LONG-TERM SAFETY; FULL-FACE INJECTIONS; BOTULINUM-TOXIN; GLABELLAR LINES; DOUBLE-BLIND; NEUTRALIZING ANTIBODIES; OPEN-LABEL;

D O I：

10.1093/asj/sjx010

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

A systematic review of the published literature (from January 2000 to January 2016) to ascertain the safety of, and patient satisfaction with, the aesthetic use of abobotulinumtoxinA was conducted. In addition to the licensed indications, other special populations were considered for discussion. The potential impact of neutralizing antibodies and systemic toxicity were also addressed. A total of 364 papers were screened and 86 were found to be relevant to the population, intervention(s), and outcomes stipulated in the protocol. The safety and patient satisfaction data from these publications are discussed in this review.

引用

页码：S32 / S44

页数：13

共 88 条

[1] A Small Study of the Relationship Between Abobotulinum Toxin A Concentration and Forehead Wrinkle Reduction
Abbasi, Naheed R.
Durfee, Melissa A.
Petrell, Kathleen
Dover, Jeffrey S.
Arndt, Kenneth A.
[J]. ARCHIVES OF DERMATOLOGY, 2012, 148 (01) : 119 - 121
[2] [Anonymous], AM AC DERM AC 2005 A
[3] [Anonymous], AHFS DRUG INFORM
[4] [Anonymous], PLAST RECONSTR SURG
[5] [Anonymous], FDA REQ BOX WARN ALL
[6] A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines
Ascher, B
Zakine, B
Kestemont, P
Baspeyras, M
Bougara, A
Santini, J
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) : 223 - 233
[7] Ascher Benjamin, 2005, Aesthet Surg J, V25, P365, DOI 10.1016/j.asj.2005.05.004
[8] Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crow's Feet: Double-Blind, Placebo-Controlled, Dose-Ranging Study
Ascher, Benjamin
Rzany, Berthold J.
Grover, Rajiv
[J]. DERMATOLOGIC SURGERY, 2009, 35 (10) : 1478 - 1486
[9] Clinical relevance of botulinum toxin immunogenicity
Benecke R.
[J]. BioDrugs, 2012, 26 (2) : e1 - e9
[10] Immunologic resistance after repeated botulinum toxin type A injections for facial rhytides
Borodic, G
[J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 22 (03) : 239 - 240

← 1 2 3 4 5 6 7 8 9 →